Both in Biotechnology
Scribe Therapeutics vs Surrozen
Over the past year SCTX returned −50.2% and SRZN returned +46.4%; their daily moves had a correlation of -0.21.
SCTX −50.2% SRZN +46.4%Growth of $1, one year, split-adjusted
| Metric | SCTX | SRZN |
|---|---|---|
| Price | $14.81 | $27.81 |
| Market cap | $280.4M | $326.9M |
| Today | −15.08% | −5.60% |
| 1 month | −13.8% | −7.3% |
| 6 months | — | −17.2% |
| Year to date | — | +23.1% |
| 1 year | — | +104.6% |
| Revenue growth (YoY) | — | +408.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 28.4× |
| Net cash | — | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 174.4% |
| Short % of float | 14.6% | 37.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).